Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
GlobeNewswire
*Allschwil, Switzerland, May 16, 2024*
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage..
IQVIA
News and Video Search Results
News coverage
-
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
-
Leading Penang-based Healthcare Provider Bags Multiple Awards at the GlobalHealth Asia-Pacific Awards 2024
PR Newswire Asia
-
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
Business Wire
-
BIO Asia-Taiwan 2024 opens July 24th
PR Newswire Asia
- More about:
COVID-19 vaccine
0 shares
1 views
You might like
IQVIA media coverage
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award Finalist in the 2024 Citeline Awards
GlobeNewswire
BOSTON, May 12, 2024 (GLOBE NEWSWIRE) -- The TrialWire™ Rapid Patient Recruitment Platform, the only pay-per-enrolled fixed-fee..
-
Walgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business
Accesswire
-
Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)
PR Newswire Asia
-
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
Business Wire
-
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
Accesswire
Advertisement
More coverage
S&P 500 Analyst Moves: IQV
Market News Video
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, IQVIA..
Se espera que el mundo gastará $157 mil millones en vacunas COVID-19 para el 2025
Cover Video LATAM STUDIO
World Projected to Spend $157 Billion on COVID-19 Vaccines by 2025
Cover Video STUDIO